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Abstract Capturing patients’ perspectives has become an
essential part of a quality of care assessment. The patient
centeredness questionnaire for PD (PCQ-PD) has been
validated in The Netherlands as an instrument to measure
patients’ experiences. This study aims to assess the level of
patient centeredness in North American Parkinson centers
and to demonstrate the PCQ-PD’s potential as a quality
improvement instrument. 20 Parkinson Centers of Excel-
lence participated in a multicenter study. Each center asked
50 consecutive patients to complete the questionnaire. Data
analyses included calculating case mix-adjusted scores for
overall patient centeredness (scoring range 0–3), six
subscales (0–3), and quality improvement (0–9). Each
center received a feedback report on their performance.
The PCQ-PD was completed by 972 PD patients (median
50 per center, range 37–58). Significant differences
between centers were found for all subscales, except for
emotional support (p\ 0.05). The information subscale
(mean 1.62 SD 0.62) and collaboration subscale (mean
2.03 SD 0.58) received the lowest experience ratings. 14
centers (88 %) who returned the evaluation survey claimed
that patient experience scores could help to improve the
quality of care. Nine centers (56 %) utilized the feedback
to change specific elements of their care delivery process.
PD patients are under-informed about critical care issues
and experience a lack of collaboration between healthcare
professionals. Feedback on patients’ experiences facilitated
Parkinson centers to improve their delivery of care. These
findings create a basis for collecting patients’ experiences
in a repetitive fashion, intertwined with existing quality of
care registries.
Keywords Parkinson’s disease  Patient experiences 
Quality of life  Outcome research  Patient-centered care
Introduction
In 2001, the National Academy of Medicine introduced six
areas to improve the quality of the US healthcare system.
These areas were built around the fundamental needs for
healthcare, which has to be safe, effective, equitable,
timely, efficient, and patient centered [1]. Patient cen-
teredness is increasingly recognized as a critical aspect and
deficiency in care delivery [1–3]. The concept can be
defined as providing care that is respectful of and
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responsive to individual preferences, and ensuring that the
patient’s needs guide all clinical decisions.
Patient-centered care reflects an ethical norm inherent to
medicine [4]. In addition to the intrinsic value, the
approach is associated with improved physical and psy-
chosocial health outcomes [5–7]. Moreover, patient cen-
teredness increases treatment adherence among chronically
ill patients [8]. The concept may lower costs by a shortened
length of stay in the hospital, decreased adverse events, and
reduced healthcare utilization [9–11].
To integrate the concept into a comprehensive assess-
ment of quality of care, we need validated instruments and
an assessment of current levels of patient centeredness
[12]. Increasingly, experience questionnaires have been
recognized to provide insight into the level of patient
centeredness [13, 14]. Moreover, improving care experi-
ences have become a key priority for health system reform
in the US [15, 16]. The Affordable Care Act mandated new
payment approaches based in part on the results of patient
experience surveys [17].
The US and England have the longest tradition of
measuring care experiences, through the Consumer
Assessment of Healthcare Providers and Systems
(CAPHS) questionnaire (US) and the Picker Institute
survey (used by the NHS). The patient centeredness
questionnaire for PD (PCQ-PD) has been developed
according to Dutch standards for measuring patients’
experiences [18]. This study aimed to validate the PCQ-
PD for use in US-based populations, to assess the level of
patient centeredness in North American Parkinson centers,
and also to demonstrate the PCQ-PD’s potential as a
quality improvement instrument.
Methods
Cross-cultural validation
A cross-cultural validation procedure was applied to the
Dutch version of the PCQ-PD to test the applicability in
National Parkinson Foundation (NPF) centers in the US
and Canada [19]. Cross-cultural validation included a
translation of the questionnaire from Dutch into English,
based on a forward–backward translation process by two
researchers and a bilingual translator, online expert
consultation with 17 movement disorders specialists and
pre-testing the face and content validity by conducting
15 cognitive interviews with health professionals,
patients, and caregivers in the UF Center for Movement
Disorders and Neurorestoration. Consequently, some
items were refined, for example, the word ‘tools’ was
changed into ‘adaptive equipment’ (Q2) and ‘comple-
mentary medicine’ into ‘alternative health thera-
pies’(Q8). Two new items were included (Q4–Q28), and
one item was removed. ‘When to start with medication’
referred to the right time to take anti-Parkinson medi-
cation; immediately after the diagnosis or during the
course of the disease. All American interviewees started
immediately. The PCQ-PD consists of 15 items on
patient characteristics, e.g., gender, age, race, and health
Table 1 PCQ-PD care aspects
Subscales Care aspects
Information 12 items Patient organizations (Q1), adaptive equipment, home care and facilities (Q2), reliable information (Q3), peer support
(Q4), medication use and side effects (Q5), reimbursement of treatment costs (Q6), contact after medication regimen
changes (Q7), alternative health therapies (Q8), advanced treatment options (Q9), ability to drive a car (Q10), find
health professionals specialized in PD (Q11), and treatment options allied health professionals (Q12)
Collaboration 11 items Leading physician (Q13), care coordinator (Q14), awareness of professionals of each other’s involvement (Q15),
mutual agreements (Q16), conflicting information (Q17), informed about what professionals discussed regarding
your treatment (Q18), cooperation second opinion (Q19), timely referrals (20), collaboration PD nurse specialist and
neurologist (Q21), collaboration between physicians (Q22), and fixed contact for questions or complaints (Q25)
Accessibility 4 items Waiting period before visiting a neurologist (Q23), waiting period in waiting room (Q24), email access (Q26), and
telephone access (Q27)
Empathy 5 items Questions answered in a timely manner (Q28), listen carefully (Q29), take enough time (Q30), explain things clearly
(Q31), and professional competence (Q32)
Patient involvement 6
items
Access to medical record (Q33), authorize who has access to your medical record (Q34), opportunity to choose your
health professional (Q35), opportunity to schedule appointments (Q36), adapt treatment to personal preferences
(Q37), and participation in treatment decisions (Q38)
Emotional support 6
items
Attention paid to the caregiver (Q39), active involvement of the caregiver (Q40), support after the diagnosis was first
communicated (Q41), support coping with the disease (Q42), support relationship changes (Q43), and support related
to employment (Q44)
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status and 44 care aspects covering six subscales of
patient centeredness (Table 1 and electronic supple-
mentary material).
Multicenter study
Data collection
North American NPF centers were invited to participate in
a multicenter study (n = 48). These centers are recognized
as leaders in Parkinson care based on their ongoing
research, comprehensive care delivery, and professional
education. In each participating center, a research coordi-
nator was assigned to distribute the PCQ-PD. Patients with
idiopathic PD, multiple system atrophy, or progressive
supranuclear palsy were included. Patients diagnosed with
severe cognitive impairment, like Lewy body disease,
corticobasal degenerative disease, Parkinson’s disease
dementia, or MMSE\24 were excluded.
Consecutive patients were asked to complete the ques-
tionnaire at the clinical site after their consultation with a
neurologist. The PCQ-PD was accompanied by an
informed consent form, a return envelope, and a cover
letter signed by local neurologists. Neither patient names
nor addresses were stated. The PCQ-PD had a center
identification number only. Completed questionnaires were
stored in a sealed envelope and returned to the research
coordinator. All centers applied for ethical approval by a
local institutional review board. The protocol was exemp-
ted from review, since patients could not be identified from
the data and the study did not involve an intervention,
specimens, or devices.
Sample size calculation
The PCQ-PD’s ability to discriminate between practices can
be determined by the Intra-class Correlation Coefficient
(ICC) [20]. The ICC accounts for the relatedness of clustered
data (here: patients clustered in Parkinson centers) by
comparing the variance within centers with the variance
between centers. High ICC values indicate greater variation
between centers, relative to variation within centers. Sample
size calculations showed that with 20 participating centers,
an estimated ICC of 5 % (95 % CI 0.01–0.14), 50 patients
had to complete the PCQ-PD per center [21].
Data processing
Completed questionnaires were processed manually, and data
were entered into SPSS. Systematic and random errors were
detected and instantly corrected by conducting frequency
analyses and by entering the data of 5 % of the questionnaires
twice (n = 50). Participants completing\50 % of the
experience items were excluded. Three items were nega-
tively phrased (Q17–23–24). Thus, a positive answer
indicated a negative experience on this aspect. Data of
these items were mirrored, allowing for comparison with
other items where higher scores indicated better
experiences.
Data analysis
For each item an Item Experience Score (IES) (0 = No,
not at all, 1 = Yes, to some extent, 2 = Yes, to a moderate
extent, and 3 = Yes, to a great extent), an Item Priority
Score (IPS), (0 = Not important, 1 = Fairly important,
2 = Important, and 3 = Extremely important), a propor-
tion of negative experiences (% respondents with IES 0 or
1), and a Quality Improvement Score (QIS) were calculated
at the center level. The latter represents those care aspects
where patients report negative experiences in combination
with high priorities and can as such be labeled as having
priority for quality improvement. QIS was calculated by
the maximum IES of 3 minus the observed IES, multiplied
by the observed IPS. Consequently, improvement scores
vary from 0 to 9; the higher the score, the higher the need
for improvement. For each center, case mix-adjusted sub-
scale scores (0–3) and an Overall Patient centeredness
Score (OPS) (0–3) were calculated using a general linear
model. To determine any differences between centers, one-
way ANOVA analysis was performed.
Discriminative power
Multivariate multilevel regression analysis was performed
to assess the discriminative power of the PCQ-PD between
centers [22, 23]. First, univariate multilevel regression
analyses were performed between patient characteristics
and subscale scores. Next, two nested models were fitted to
the data. The first model was a random-intercept model
without explanatory variables (0-model). The second
model was performed with patient characteristics as fixed
effects (1-model). Casemix adjusters with a p value\0.20
in the univariate regression analysis were included in the
multivariate regression model using a backward selection
procedure [24]. Discriminative power was determined by
calculating ICCs for each subscale in both the 0 and 1
model, with a random intercept at the center level. To
assess how much variance in each 0-model is attributable
to differences in patient characteristics, the proportional
change in variance was calculated [25].
Feedback reports
Each center received a feedback report on their level of
patient centeredness. The report included an Overall
2530 J Neurol (2015) 262:2528–2538
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Patient centeredness Score (OPS) and subscale scores
anonymously benchmarked against other centers. Addi-
tionally, Quality Improvement Scores (QIS) and patients’
qualitative feedback were presented. Hereby, health pro-
fessionals could identify care aspects with the highest
priority for improvement in their own center. Profes-
sionals were encouraged to discuss the report within their
medical team but were free to change aspects of care that
needed improvement according to their patients. After
3 months, medical directors and research coordinators
received a survey to evaluate the impact of the feedback
report.
Results
Respondents
20 Parkinson Centers of Excellence participated in this
study (center participation rate 41.7 %). The PCQ-PD was
completed by 972 PD patients (median 50 per center, range
37–58). 17 patients were excluded based on having another
diagnosis, and this included depression, essential tremor,
dementia, or dystonia (n = 7), or because of completing
\50 % of the experience items (n = 10). Patient charac-
teristics of all respondents are shown in Table 2.
Table 2 Patient characteristics
Net response N 955
Respondents per center Median (range) 50 (37–58)
Age (years) Median (range) 69.0 (32–93)
Gender n (%) women 377 (38.8)
Level of education n (%) college or university degree 501 (52.5)
n (%) technical or community college 75 (7.9)
n (%) college no degree 157 (16.5)
n (%) high school 170 (17.8)
n (%) less than high school 51 (5.3)
Diagnosis Parkinson’s disease 928 (97.2)
Parkinsonism (MSA and PSP) 27 (2.8)
Disease duration (years) Median (range) 7.0 (1–40)
Self-reported Hoehn and Yahr disease stage n (%) HY1 306 (32.5)
n (%) HY2 190 (20.2)
n (%) HY3 374 (39.7)
n (%) HY4 49 (5.2)
n (%) HY5 22 (2.3)
Self-reported physical health status n (%) excellent 70 (7.4)
n (%) very good 301 (31.6)
n (%) good 387 (40.7)
n (%) fair 165 (17.3)
n (%) poor 29 (3.0)
Self-reported mental health status n (%) excellent 155 (16.3)
n (%) very good 363 (38.1)
n (%) good 298 (31.3)
n (%) fair 116 (12.2)
n (%) poor 20 (2.1)
Race n (%) Caucasian 671 (93.6)
n (%) African American 17 (2.4)
n (%) Asian 14 (2.0)
n (%) American Indian or Alaska native 2 (0.3)
n (%) other 13 (1.8)
Overall quality of care n (%) excellent 603 (62.6)
n (%) very good 265 (27.5)
n (%) good 77 (8.0)
n (%) fair 15 (1.6)
n (%) poor 3 (0.3)
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Overall patient centeredness and subscale scores
The information subscale [mean 1.62 (SD 0.62)] and col-
laboration subscale [mean 2.03 (SD 0.58)] received the
lowest experience ratings. Accessibility of care [mean 2.49
(SD 0.55)] and empathy [mean 2.63 (SD 0.52)] received
the highest experience ratings. The Overall Patient cen-
teredness Score (OPS) and casemix-adjusted subscale
scores for each center are shown in Fig. 1. OPS ranged
from 1.87 (95 % CI 1.74–2.00) for the worst performing
center to 2.23 (2.11–2.36) for the best (d 0.36). Subscale
scores ranged from 1.89 to 2.68 (d 0.79) for patient
involvement; 1.61–2.29 (d 0.68) for collaboration;
1.83–2.44 (d 0.61) for emotional support; 2.15–2.71 (d
0.56) for accessibility; 1.37–1.88 (d 0.51) for information;
and 2.47–2.81 (d 0.34) for empathy.
Quality Improvement Scores(QIS)
The item with the highest QIS 4.80 was ‘Were you
informed about what your health professionals discussed
with each other regarding your treatment?’(Table 3).
80.3 % of the respondents indicated to have a negative
experience on this item. Care aspects with the highest
potential for improvement are all information and collab-
oration subscale items. Care aspects with the highest
Fig. 1 Level of patient
centeredness in North American
Centers of Excellence. The dots
and boxes in Fig. 1 represent
casemix-adjusted mean scores
per subscale for each center.
The horizontal lines in each
boxplot represent the minimum,
first quartile, median, third
quartile, and maximum score
per subscale. Dots plotted
outside the boxplot are outliers.
The OPS and subscale scores
for the total study population are
presented below Fig. 1
Table 3 Quality Improvement Scores
Item Subscale %NE IES
(0–3)
IPS
(0–3)
QIS
(0–3)
Q18 Informed about what professionals discussed with each other regarding your
treatment
Collaboration 80.3 0.80 2.19 4.80
Q8 Informed about alternative health therapies Information 71.0 1.03 2.07 4.08
Q7 Being contacted after a new medication regimen Information 61.1 1.22 2.21 3.94
Q9 Informed about advanced treatment options Information 62.6 1.33 2.24 3.73
Q16 Mutual agreements about your treatment Collaboration 60.9 1.30 2.16 3.68
Q2 Informed about adaptive equipment, home care and facilities Information 73.5 1.03 1.72 3.39
Q1 Informed about Parkinson’s disease patient organizations Information 75.3 0.95 1.55 3.17
Q22 Collaboration between physicians Collaboration 46.7 1.73 2.39 3.05
Q10 Informed about ability to drive a car Information 50.1 1.61 2.10 2.93
Q12 Informed about treatment options allied health professionals Information 41.8 1.80 2.44 2.92
%NE the proportion of patients with a negative experience with that aspect, IES Item Experience Score, IPS Item Priority Score, QIS Quality
Improvement Score = (3 - IES) 9 IPS
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priority scores were all empathy subscale items. However,
these items had low QIS, as patients experience good care
on these aspects.
Evaluation of the feedback reports
Eight medical directors and 12 research coordinators rep-
resenting 16 centers (80 %) returned the evaluation survey.
All respondents read the report and all but two discussed
the report within their medical team. Moreover, nine cen-
ters (56 %) shared the results with patients in the waiting
room. The feedback report was perceived as a useful tool
for internal quality improvement by 14 centers (88 %).
Respondents stated that the report easily identified areas to
work on and revealed invaluable information from the
patient’s perspective. Additionally, nine centers (56 %)
used the feedback to change specific elements within their
care delivery process illustrated by the following state-
ments: ‘‘We altered the pre-appointment checklist to ask
patients to provide more input into their care (#3); We took
the top five items cited for improvement and are digging
down into them more. We started a project that will allow
for better driver screening (#11); We developed a center
information sheet to new patients that provides explicit
information about available resources (#13). Patients are
given an email to contact the physician after 2–3 weeks in
the medications changes (#14).We have changed the way
we are addressing the waiting list (#17) and; We have
added additional providers to increase accessibility and are
increasing the referrals in the patient’s area of residence
(#26).’’
Discriminative power of the PCQ-PD
One-way ANOVA analysis showed significant differences
between centers on overall patient centeredness and all
subscales, except for emotional support (p\ 0.05). Table 4
demonstrates the multilevel analysis results. Regression
coefficients (column 3–9) show that gender, level of edu-
cation, physical and mental health status, disease stage,
language, and race are significantly related to patient cen-
teredness scores. For example, a higher level of education
is associated with more positive experiences toward
information, patient involvement, and empathy. Con-
versely, women perceived less access to healthcare com-
pared to men. The proportional change in variance shows
that patient characteristics explain 0.7 % for emotional
support to 11.8 % for information of the total variance
detected in the 0 models. ICC values demonstrate that
differences between centers were accountable for 1–6 % of
the variance in patient centeredness.
Discussion
Main results
Application of the PCQ-PD in a large cohort showed that
North American PD patients are under-informed about
critical care issues and experience a lack of collaboration
between members of their healthcare team. Moreover,
significant differences in patient centeredness between the
participating centers were found. Feedback on patients’
experiences stimulated half of the centers to change the
delivery of care at their individual center. Here, we will
discuss the potential significance of these findings.
This study showed that PD patients are under-informed
about critical aspects of their care, as was found previously
[18, 26, 27]. A qualitative study from New Zealand on
unmet needs showed that PD patients wanted their physi-
cians to offer more information about their condition [26].
Moreover, a British study demonstrated that PD patients
were poorly informed about medication and treatment
options [27]. Application of the PCQ-PD in a large Dutch
sample certified that patients were in need for information
regarding alternative health therapies and treatment options
of allied health professionals [18]. These findings reflect
the complexity of providing the right information to the
right person at the right time. Considerable individual
differences in information needs exist, while each disease
stage induces new information requirements [28]. Stratifi-
cation of patients’ needs by disease stage and online-per-
sonalized information might facilitate healthcare providers
to target information to patient subgroups [29].
PD patients were not aware of mutual consultation and
sound agreements between members of their healthcare
team. Moreover, patients were not informed about what
health professionals discussed with each other regarding
their treatment. Two previous studies confirm that Dutch
patients experience a lack of collaboration between pro-
fessionals in the exact same way [18, 30]. An integrated
approach including the patient as part of the team is
thought to be the best way to manage PD [31]. However,
evidence quantifying positive and sustained effects of such
an approach remains inconclusive [31, 32]. Novel care
models, fostering the interaction between healthcare pro-
viders and patients and online exchange of medical data,
may facilitate multidisciplinary collaboration in healthcare
[29].
Feedback on patients’ experiences stimulated health
professionals to improve the delivery of care at their
individual center. Three months after receiving the report,
half of the centers had changed specific elements of their
care delivery process. However, feedback did not encour-
age all centers to improve; some centers discussed the
J Neurol (2015) 262:2528–2538 2533
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report within their medical team but did not know how to
convert the feedback into a practicable action plan.
Increasing the desire to change and improving the ability to
translate feedback into an optimal improvement strategy
are necessary future steps [33]. Furthermore, the content
and timing of feedback are important [34]. Long-term
conditions such as PD, require audits and feedback at
regular intervals, provided to various levels of staff, in both
verbal and written formats, and should include explicit
targets to accomplish behavioral change [35].
This study uncovered significant differences in the level
of patient centeredness between North American Parkinson
centers. These differences may reflect meaningful varia-
tion; however, multilevel analysis revealed that differences
between centers were accountable for only 1–6 % of the
variance in patient centeredness. These values suggest that
variation in experience scores occurred mainly at the
patient level and to a lesser extent at the center level.
Casemix adjustment did not change this result. Limited
discriminative power is a common finding in experience
surveys and may have resulted from the homogeneity of
participating centers in our study [36]; all of these were
established Centers of Excellence recognized by the
American NPF. However, NPF centers do provide different
services, resources, and professional disciplines on a cen-
ter-by-center basis without standardization. Stratification
for hospital factors might increase benchmark validity in
future studies. Additionally, unknown confounders may
have obliterated the variation between centers [36]. Lim-
ited discriminative power suggests that patients’ experi-
ences can be used for feedback and to rank the best and the
worst performing centers but should not be utilized to list
all centers in a consecutive order. If new payment models
depend in part on care experiences, the discriminative
power of experience surveys should be raised.
Strengths
First, cross-cultural validation contributed to the face and
content validity of the PCQ-PD. We applied cognitive
interviews to evaluate sources of response error in the
questionnaire [19]. The PCQ-PD was developed based on
the outcomes of eight focus group discussions in The
Netherlands [30]. Some care aspects mentioned in these
discussions were not found to be relevant for patients in the
US, and it was necessary to rephrase some items. Overall,
Dutch and North American patients showed similar values
and needs.
Second, we applied casemix adjustment which is nec-
essary for valid comparisons of care experiences across
centers [22]. International studies confirm that patients’
experiences differ significantly depending on age, educa-
tion, and health status [24, 37, 38]. Researchers agree thatT
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the effect of casemix adjustment is modest, and patients’
characteristics only predict a small percentage of the
variability [36]. Nevertheless, when patients’ experiences
are used for benchmarking, hospital ranks are substantially
affected by casemix adjustment [22].
Shortcomings
Our study was not without shortcomings. First, we included
27 patients suffering from atypical Parkinsonism, who may
have dissimilar needs and may utilize different healthcare
resources. However, these patients are part of the average
patient population seen by NPF centers, and data analysis
showed that their experiences did not deviate from patients
with idiopathic PD. Additionally, NPF centers are more
likely to routinely employ best practices in PD care and
therefore most likely provide an overestimation of the level
of patient centeredness when compared to general Parkin-
son care settings. Our patient mix analysis showed that
participants were highly educated, English speaking, non-
Hispanic, Caucasian, and all covered by health insurance.
These features do not completely reflect the US and
Canadian population and may demonstrate inequitable
access to high qualitative Parkinson care [39]. Future work
also needs to study patient centeredness among these
populations, and within centers that mainly serve these
populations [40].
Second, patients were asked to self-rate their disease stage
to facilitate the inclusion procedure. Normally, disease stage
is classified by clinicians using the Hoehn and Yahr rating
scale. We found that most medical records did not contain
up-to-date disease stage ratings. Pragmatically, we therefore
included self-reported medical data instead of performing
actual physical examinations. This approach is not infallible,
as some patients may find it hard to review whether the
disease affects one or both sides of the body. Moreover,
patients might complain about unilateral involvement, while
the neurological evaluation shows bilateral involvement
with regard to bradykinesia or rigidity. However, this inac-
curacy was equally distributed among centers in our study.
Ideally, future studies aimed at exploring care experiences
should link these to up-to-date medical information stored
within electronic health records.
Future perspective
The study provided a first step to increase awareness on
patient-centered care in North-American Parkinson centers.
Such findings create a basis for collecting patients’ expe-
riences in a repetitive fashion and intertwined with existing
quality of care registries. This will allow for comparisons
of the patient’s perspective with the provided treatment,
clinical outcomes, and costs. The data should become
publicly available enabling direct comparisons across
institutions and utilized to credit health professionals for
providing patient-centered care.
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